Aarkstore.com - Global Breast Cancer Market Report: 2014 Edition
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Breast cancer knows no boundaries be it age, gender, socioeconomic status or geographic location. The most common risk factors for breast cancer are being female and growing older. See Full Report : http://bit.ly/1wRG4Cc
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Breast cancer knows no boundaries be it age, gender, socioeconomic status or geographic location. The most common risk factors for breast cancer are being female and growing older.
See Full Report : http://bit.ly/1wRG4Cc
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Aarkstore</strong> Enterprise<br />
1 st September <strong>2014</strong><br />
<strong>Global</strong> <strong>Breast</strong> <strong>Cancer</strong> <strong>Market</strong> <strong>Report</strong>: <strong>2014</strong> <strong>Edition</strong><br />
<strong>Breast</strong> cancer is the most frequently diagnosed cancer and the leading cause of cancer<br />
death in women. <strong>Breast</strong> cancer knows no boundaries be it age, gender, socioeconomic<br />
status or geographic location. The most <strong>com</strong>mon risk factors for breast cancer are<br />
being female and growing older.<br />
In the past few years, the cases of breast cancer have increased tremendously in<br />
regions like the US and the Europe. The breast cancer market is driven by various<br />
factors like aging population in women, obesity and diabetes, hormonal factors, race<br />
and ethnicity and family history. A major trend which will probably remain eternally<br />
in the breast cancer treatment industry is the fact that novel and innovative<br />
technologies and pharmaceutical molecules are always under to effectiveness and<br />
advancements in technology, a large number of <strong>com</strong>panies are focusing to develop<br />
innovative breast cancer drugs. Further, the <strong>com</strong>panies are forming alliances and<br />
agreements to develop effective treatment methods for breast cancer.<br />
The present report provides a <strong>com</strong>prehensive analysis of the global breast cancer<br />
diagnosis and treatment market with focus on regions like the US, India, China and<br />
Brazil. Furthermore, market dynamics such as the industry trends and development,<br />
the underlying growth drivers and major issues faced by the industry are elicited. On<br />
the contention front, the market is personified by the intense <strong>com</strong>petition in terms of<br />
research and development of novel therapeutic molecules. The leading players<br />
operating in the industry include Hologic, Johnson and Johnson, Siemens AG, Roche<br />
and Novartis which are also profiled in this report.
<strong>Aarkstore</strong> Enterprise<br />
Browse <strong>com</strong>plete <strong>Report</strong> on :<br />
http://www.aarkstore.<strong>com</strong>/healthcare/49093/<strong>Global</strong>-<strong>Breast</strong>-<strong>Cancer</strong>-<strong>Market</strong>-<br />
<strong>Report</strong>-<strong>2014</strong>-<strong>Edition</strong><br />
Table of Content:<br />
1. <strong>Market</strong> Overview<br />
1.1 <strong>Breast</strong> <strong>Cancer</strong><br />
1.2 Types Of <strong>Breast</strong> <strong>Cancer</strong><br />
1.3 Risk Factors<br />
1.4 Symptoms Of <strong>Breast</strong> <strong>Cancer</strong><br />
1.5 Diagnosis And Treatment Of <strong>Breast</strong> <strong>Cancer</strong><br />
1.5.1 <strong>Breast</strong> <strong>Cancer</strong> Screening And Diagnostic Measures<br />
1.5.2 <strong>Breast</strong> <strong>Cancer</strong> Treatment<br />
2. <strong>Breast</strong> <strong>Cancer</strong> <strong>Market</strong><br />
2.1 <strong>Global</strong> <strong>Market</strong><br />
-<strong>Market</strong> Value<br />
-<strong>Market</strong> Segments<br />
2.2 <strong>Breast</strong> <strong>Cancer</strong> Diagnostics <strong>Market</strong><br />
2.2.1 The US<br />
2.2.2 Brazil<br />
2.2.3 India<br />
2.2.4 China<br />
2.3 <strong>Breast</strong> <strong>Cancer</strong> Therapeutics <strong>Market</strong>
<strong>Aarkstore</strong> Enterprise<br />
2.3.1 Regional Analysis<br />
2.3.2 Metastatic <strong>Breast</strong> <strong>Cancer</strong><br />
-The US<br />
-Europe<br />
-China<br />
3. <strong>Market</strong> Dynamics<br />
3.1 Industry Developments<br />
3.1.1 Diagnostic Tests<br />
3.1.2 New Drugs & Therapies<br />
3.2 Growth Drivers<br />
3.2.1 Increasing Prevalence Of <strong>Cancer</strong> Cases<br />
3.2.2 Increasing Use Of Tobacco And Alcohol<br />
3.2.3 Expanding Obese And Diabetes Population<br />
3.2.4 Rising Demand For Better Healthcare Options<br />
3.2.5 Growing Women Population (+45 Years)<br />
3.2.6 Increased Spending On Medicines<br />
3.2.7 Dense <strong>Breast</strong> Tissue<br />
3.2.8 Race\Ethnicity<br />
3.2.9 Exposure To Oestrogen<br />
3.2.10 Hormonal Factors Or HRT (Hormone Replacement Therapy)<br />
3.2.11 Exposure To Radiation<br />
3.3 Challenges<br />
3.3.1 Rising Costs Of Treatment<br />
3.3.2 Stringent Regulatory Measures
<strong>Aarkstore</strong> Enterprise<br />
3.3.3 Adverse Effects Of The Treatment<br />
3.3.4 Mounting Price Pressure<br />
4. Competitive Landscape<br />
-Competitive Overview<br />
-<strong>Market</strong> Share<br />
5. Company Profiles<br />
5.1 Hologic, Inc.<br />
5.1.1 Business Overview<br />
5.1.2 Financial Overview<br />
5.1.3 Business Strategies<br />
-Focus On Research & Development<br />
-Business Expansion Via Acquisitions<br />
5.2 Johnson & Johnson<br />
5.2.1 Business Overview<br />
5.2.2 Financial Overview<br />
5.2.3 Business Strategies<br />
-Research And Development Activities<br />
-Strategic Acquisitions<br />
5.3 F. Hoffmann-La Roche Ltd<br />
5.3.1 Business Overview<br />
5.3.2 Financial Overview<br />
5.3.3 Business Strategies<br />
-Accelerating R&D Activities<br />
-Building On Strength In Biotechnology
<strong>Aarkstore</strong> Enterprise<br />
5.4 Novartis<br />
5.4.1 Business Overview<br />
5.4.2 Financial Overview<br />
5.4.3 Business Strategies<br />
-Focus On R&D Activities<br />
-Business Expansion Via Acquisitions<br />
5.5 Siemens AG<br />
5.5.1 Business Overview<br />
5.5.2 Financial Overview<br />
5.5.3 Business Strategies<br />
-Optimum Allocation Of R&D Resources<br />
-Focus On Healthcare Segment<br />
List Of Tables<br />
Stages Of <strong>Breast</strong> <strong>Cancer</strong><br />
New Cases Of <strong>Breast</strong> <strong>Cancer</strong> And Estimated Deaths In The US (<strong>2014</strong>E)<br />
The US Tomosynthesis <strong>Market</strong> Opportunity<br />
Neuvax / E75 (Nelipepimut) Estimated Sales <strong>Breast</strong> <strong>Cancer</strong> <strong>Market</strong> Size Model<br />
(2017E-2020E)<br />
The US MBC <strong>Market</strong> (In US$ Million) 2010-2015E<br />
European MBC <strong>Market</strong> (In US$ Million) 2010-2015E<br />
Metasite <strong>Breast</strong> And Menacalc Are Mechanistically Different From Existing<br />
Genebased Tests<br />
<strong>Breast</strong> <strong>Cancer</strong> Drugs & Agents In Clinical Development<br />
Number Of <strong>Cancer</strong> Cases Worldwide (2012)<br />
IARC And WCRF/AICR Evaluations Of <strong>Breast</strong> <strong>Cancer</strong> Risk Factors<br />
FDA Regulation Of Medical Devices<br />
Comparison Of Adjuvant Chemotherapy Tests In <strong>Breast</strong> <strong>Cancer</strong><br />
J&Js R&D Statistics (2012 & 2013)
<strong>Aarkstore</strong> Enterprise<br />
List Of Figures<br />
Types Of <strong>Breast</strong> <strong>Cancer</strong><br />
Various Biopsy Methods<br />
<strong>Global</strong> Oncology Spending (2010-<strong>2014</strong>E)<br />
<strong>Global</strong> <strong>Breast</strong> <strong>Cancer</strong> <strong>Market</strong> By Segments (2013E)<br />
<strong>Global</strong> <strong>Breast</strong> <strong>Cancer</strong> Predictive Diagnostic And Drug Technologies (2010-<strong>2014</strong>E)<br />
The US <strong>Breast</strong> Imaging Systems <strong>Market</strong> (2010-<strong>2014</strong>E)<br />
The US Digital Mammography <strong>Market</strong> (2010-2013)<br />
Brazils <strong>Breast</strong> <strong>Cancer</strong> Imaging <strong>Market</strong> (2010-<strong>2014</strong>E)<br />
Indias <strong>Breast</strong> Screening <strong>Market</strong> (2010-<strong>2014</strong>E)<br />
Chinas <strong>Breast</strong> Screening <strong>Market</strong> (2010-<strong>2014</strong>E)<br />
<strong>Global</strong> <strong>Breast</strong> <strong>Cancer</strong> Therapeutics <strong>Market</strong> (2010-<strong>2014</strong>E)<br />
<strong>Breast</strong> <strong>Cancer</strong> Therapeutics <strong>Market</strong> By Region<br />
The US Metastatic <strong>Breast</strong> <strong>Cancer</strong> <strong>Market</strong> Revenues (2010-<strong>2014</strong>E)<br />
Chinese Metastatic <strong>Breast</strong> <strong>Cancer</strong> <strong>Market</strong> Revenues (2010-<strong>2014</strong>E)<br />
<strong>Breast</strong> <strong>Cancer</strong> Drug Breakdown In China (2013E)<br />
Different Types Of <strong>Cancer</strong> Worldwide (2012)<br />
Increasing Prevalence Of Diabetes By Region (2000-2030E)<br />
<strong>Global</strong> Female Population, +45 Years (2008-<strong>2014</strong>E)<br />
<strong>Global</strong> Spending On Medicines (2007-2017E)<br />
New Female <strong>Breast</strong> <strong>Cancer</strong> Cases And Deaths By Age, US, (2013)<br />
<strong>Global</strong> Oncology Pharmaceuticals - <strong>Market</strong> Share (2013E)<br />
<strong>Global</strong> <strong>Breast</strong> <strong>Cancer</strong> Diagnostics <strong>Market</strong> Share (2013E)<br />
Hologics Revenue Share By Business Segment (2013)<br />
Hologics Revenues (2009-2013)<br />
Johnson & Johnsons Revenues (2009-2013)<br />
F. Hoffmann-La Roche - Business Segments (2013)<br />
Roche Revenues (2009-2013)<br />
Novartis Business Segments (2013)<br />
Novartis Revenues (2009-2013)<br />
Siemens Ags Revenue By Business Segments (2013)<br />
Siemens Ags Revenues & Net In<strong>com</strong>e (2009-2012)
<strong>Aarkstore</strong> Enterprise<br />
Related reports:<br />
<strong>Global</strong> Blood Plasma <strong>Market</strong> <strong>Report</strong>: <strong>2014</strong> <strong>Edition</strong><br />
Medical Tourism <strong>Market</strong> <strong>Report</strong>: <strong>2014</strong> <strong>Edition</strong><br />
Healthcare market research<br />
About <strong>Aarkstore</strong> Enterprise<br />
<strong>Aarkstore</strong> Enterprise is a leading provider of business and financial information and<br />
solutions worldwide. We specialize in providing online market business information<br />
on market research reports, books, magazines, conference at <strong>com</strong>petitive prices, and<br />
strive to provide excellent and innovative service to our customers.<br />
You can order full <strong>Report</strong> with TOC and Sample page visit<br />
http://www.aarkstore.<strong>com</strong>/healthcare/49093/<strong>Global</strong>-<strong>Breast</strong>-<strong>Cancer</strong>-<strong>Market</strong>-<br />
<strong>Report</strong>-<strong>2014</strong>-<strong>Edition</strong>
<strong>Aarkstore</strong> Enterprise<br />
Contact Details:<br />
Pranita Roy<br />
<strong>Aarkstore</strong> Enterprise<br />
Phone: +91 998 729 5242<br />
Email: enquiry@aarkstore.<strong>com</strong><br />
Our Website: http://www.aarkstore.<strong>com</strong><br />
Facebook: https://www.facebook.<strong>com</strong>/aarkstoredot<strong>com</strong><br />
Linkedin: http://www.linkedin.<strong>com</strong>/<strong>com</strong>pany/aarkstore-enterprise
Change language